# Evaluation of the SENSEI® Laparoscopic Tethered Gamma Probe for 99mTc-nanocolloid Sentinel Lymph Node Biopsy in Prostate Cancer

> **NCT04632251** · NA · UNKNOWN · sponsor: **Lightpoint Medical Limited** · enrollment: 56 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **DEVICE:** SENSEI®

## Key facts

- **NCT ID:** NCT04632251
- **Lead sponsor:** Lightpoint Medical Limited
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-09-16
- **Primary completion:** 2021-02-16
- **Final completion:** 2021-08
- **Target enrollment:** 56 (ESTIMATED)
- **Last updated:** 2020-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04632251

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04632251, "Evaluation of the SENSEI® Laparoscopic Tethered Gamma Probe for 99mTc-nanocolloid Sentinel Lymph Node Biopsy in Prostate Cancer". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT04632251. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*